MASCC/ISOO 2015 Annual Meeting Webcasts
June 25-27, Copenhagen, Denmark 


 GO TO 2015 MASCC/ISOO Annual Meeting webcasts

Thursday, June 25th

Euthanasia, Assisted Dying

  • Pro - D. Lossignol

Use of Cannabinoids in Cancer Therapy and Supportive Care

  • State-of-the-art lecture  - D. Walsh

Skin Toxicity and Toxicity of Target Agents

  • Meta-analysis: Hypertension risk in selected targeted agents  - C. Escalante
  • Antiangiogenic-specific adverse events in patients with non-small-cell lung cancer treated with nintedanib and docetaxel  - A. Mellemgaard
  • Expert opinion  - D.M.K. Keefe
  • Low-level laser therapy for the management of radiation dermatitis: final result of the dermis trial, a pilot study in breast cancer patients  - J. Mebis
  • Palmar plantar erythrodysesthesia prevention with atorvastatin and polyprenol  - S. Kuznecovs
  • Expert opinion  - M. E. Lacouture

Pro and Con Discussion: Antithrombotic Agents for Every Patient with Incurable Cancer?

  • Pro  - M. Dicato
  • Con - F. Strasser

Management of Nausea and Vomiting in Advanced Cancer

  • State-of-the-art lecture  - M. Davis

Friday, June 26th

Bone and Neurological Complications and Nausea and Vomiting

  • Prevalence of low bone mass and osteoporosis in women diagnosed with gynecologic cancer  - B. Edwards
  • A Randomized, Phase 3, double-blind study of intravenous fosaprepitant as a single dose for preventing chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy  - B.Rapoport
  • Expert opinion  - F. Roila
  • Prevention of neuropathy using calmangafodipir: Results from a phase I study and a placebo-controlled randomized study in patients with metastatic colorectal cancer  - D. Mahalingam
  • Expert opinion  - C. Loprinzi

Endocrine Issues in Cancer

  • Obesity, diabetes and cancer outcome  - P. Goodwin
  • Hypothyroidism after radiotherapy  - M.F. Ronjom
  • Endocrine disorders following treatment with tyrosine kinase inhibitors  - F. Roila
  • Incidence of diabetes induced by high-dose glucocorticoid treatment in cancer patients  - H. Schultz
  • Conclusion  - H.P. Eikesdal

Steven M. Grunberg Memorial Award Session: Pharmaceutical Supportive Care

  • Pharmacogenomics in supportive care  - A.Chan
  • Unmasking side effects from “first-in-man’ antineoplastic medicine  - U. Lassen
  • New developments in personalised supportive care medicine  - D.M.K. Keefe

Cancer Therapy-Induced Cardio-Pulmonary Toxicity

  • Cardiotoxicity induced by chemotherapy and targeted therapy  - M. Ewer
  • Pulmonary toxicity induced by chemotherapy and targeted agents  - R Gralla
  • Primary versus secondary cardiotoxicity of anti-cancer treatment: A distinction with broad implications  - M.S. Ewer

Optimizing Contemporary Cancer Treatment Through Effective Use of Biosimilars

  • Biosimilars’ impact in cancer supportive care and the roadmap for the future  - P. Cornes
  • The European biosimilar experience in supportive cancer care  - M. Aapro

Parenteral Nutrition in Advanced Cancer?

  • D. Walsh
  • Pro  - F. Strasser
  • Con  - E. Bruera

Palliative Care

  • A diagnostic model for impending death in patients with advanced cancer  - D. Hui
  • Prognostic evaluation in palliative care: Final results from a prospective cohort study  - P. Ermacora
  • Expert opinion  - F. Strasser
  • Chemical compatibility/stability of commonly used drug combinations administered by continuous subcutaneous infusions for end-of-life care  - A. Dickman
  • Expert opinion  - A.Chan

Supportive Care in the Elderly

  • Is cancer symptom control any different in older adult cancer patients?  - A. Jatoi
  • Pain control in the elderly  - E. Bruera
  • Input of a pharmacist-led medication evaluation in the management of older patients with cancer  - M. Aitichou
  • Charlson Comorbidity Index as a predictor of overall survival of patients with early-stage NSCLC  - S. Jeppesen

Rehabilitation and Survivorship

  • Comparing the costs of three prostate cancer follow-up strategies: A cost-minimisation analysis  - L. Sharp
  • Implementation of the prostate cancer supportive care program, a comprehensive approach for men with prostate cancer and their partners  - C.S Higano
  • Quality of life, health and personal wellbeing up to two years following curative intent colorectal cancer surgery: Results from the UK colorectal wellbeing study  - C. Foster
  • Preoprative anaemia and blood transfusion as prognostic factors for mortality in colorectal cancer: A Swedish cohort study  - M. Mörner 
  • Improving adherence to cancer treatment by addressing quality of life in patients with advanced gastrointestinal cancer  - J. Basford
  • Impact and feasibility of an exercise program during chemo-radiotherapy in head and neck cancer survivors: A randomized control trial  - S.R Samuel
  • Sexuality and sexual function one year after allogeneic hematopoietic stem cell transplantation - K. Nørskov

Guidelines and Education

  • Developing an evidence-based guideline for management of dyspnea in cancer patients: Description of the MASCC Respiratory Study Group task  - S. Ahmedzai
  • Proactive approach: Developing and implementing guidelines for treating patients with orally-administered anti-cancer drugs in the home care setting: Experience of a comprehensive cancer center  - T. Granot
  • Oncology nursing society putting evidence into practice: Synthesis of evidence-based interventions for adherence to oral agents for cancer  - C. Rittenberg
  • Strengths, weaknesses and areas for improvement: A comparative survey of undergraduate palliative care education across all UK medical schools  - S. Walker

Gastrointestinal Toxicity

  • Antiemesis prophlylaxis among breast cancer patients receiving anthracyline-based chemotherapy: A population-based study  - M. Chaves MacGregor
  • Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of highly or moderately emetogenic chemotherapy  - B. Rapoport
  • Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: A randomized controlled study  - S. Mukhopadhyay
  • The oral administration of the brain-penetrating ghrelin agonist HM01 antagonizes cisplatin-induced emesis in suncus murinus  - J. Rudd
  • Single versus multiple-day corticosteroid dosing for delayed chemotherapy-induced nausea and vomiting  - P. Ng
  • Tight junction disruption is seen in the oral cavity of patients receiving standard dose chemotherapy  - H. Wardill
  • Development and validation of a patient-reported assessment tool for systemic therapy-induced diarrhea  - M. Lui
  • Association between oral microbiome and mucositis in hematopoietic stem cell transplant subjects  - F.B. Mougeot

Anemia, Febrile Neutropenia and Thrombosis

  • Practical application of a febrile neutropenia pre-printed order/algorithm incorporating the MASCC Index within a large regional emergency department  - L.A. Martin
  • Assessment of a nomogram for predicting serious complications in patients from the University of Salamanca Hospital Febrile Neutropenia Registry  - I. Matos
  • Northern Ireland’s experience of improving initial neutropenic sepsis management through a multidisciplinary integrated care pathway and care bundle  - C. Forde
  • Trajectory of hemoglobin level during treatment of selected myelosuppressive chemotherapy regimens for breast cancer  - C. Chao
  • Leaning upon international directives for optimization: Anemia results of the French Lidoanemia Survey  - V. Launay-Vacher
  • Venous thrombolism in cancer: a prospective study  - A. A. Dhir

Psychooncology and Quality of Life

  • Cancer caregiver quality of life: Need for targeted intervention  - M. Lapid
  • Expectation effects in endocrine treatment of breast cancer: A two-year perspective clinical cohort study  - Y. Nestoriuc
  • The contribution of informal caregivers in cancer care, and patient factors associated with caregiver outcomes  - A. Ugalde
  • Quality of life in elderly/frail patients with glioblastoma multiforme: Results of the IAEA randomized phase 3 study comparing short and standard courses of radiotherapy  - E. Fidarova
  • Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Revealing a state of blissful ignorance?  - S. Tabchi
  • Conflict, parent distress, family strain and health-related symptoms in long-term survivors of childhood acute lymphoblastic leukemia  - I. Huang

Complementary and Alternative Medicine in Cancer Care

  • Complementary and alternative medicine in cancer care: New data call for mind shifting?  - A. Charalambous
  • What is the evidence of CAM in cancer patients?  - H. Johannessen
  • Clinical use of CAM in cancer patients  - A. Molassiotis
  • Complementary medicine education for oncology professionals in Alberta: evaluation of an online program - G.T. Levin

Palliative Care

  • Exploring the complexities of caregiver quality of life: Qualitative results from a trial of early palliative care  - J. McDonald
  • Differences in attitudes and beliefs toward cancer treatments at the end of life between hematologic and solid tumor oncology specialists  - D. Hui
  • The frequency, characteristics and outcomes among cancer patients with delirium admitted to an acute palliative care unit  - M. de la Cruz
  • Sleep disturbance contributes to CRF in cancer patients with active disease  - D. Balachandran

Radiotherapy-Induced Late Toxicities in Cancer Survivors

  • Late complications induced by radiotherapy on head and neck cancer patients  - P. Feyer
  • Cardiotoxicity induced by radiotherapy  - S. Derby
  • Gastrointestinal late complications of radiotherapy  - A.Muls

Use of E-Health in Supportive Care

  • E-health empowered health: nurses’ experience  - B. Westman
  • How can E-health increase adherence to cancer therapy and supportive care? Physicians’ experience  - D.M.K. Keef
  • E-Health: Patients’ experience  - J. Pelouchova

Oral Care in Head and Neck Cancer

  • Focus on taste disturbances  - A.G. Boltong
  • Focus on nutrition  - H. Jager-Wittenaar
  • Stimulated residual salivary gland function is correlated to mean radiation dose delivered to the major salivary glands during radiotherapy for head and neck cancer  - R. Zukauskaite
  • Oral and dental status in long-term survivors of allogeneic HSCT performed in children, adolescents and young adults: Preliminary results  - K.E. Tanem

Bone Marrow Toxicity

  • Anemia in cancer: An update on the use of iron, EPO and activin receptor antagonists  - M. Aapro
  • Febrile neutropenia: An update on outpatient management of low-risk patients  - J. Klastersky
  • Febrile neutropenia: An update on management of high-risk stem-cell transplantation patients  - W. Hogan
  • Thrombocytopenia and thrombopoietin  - M. Dicato
  • Intravenous iron isomaltoside 1000 as monotherapy in comparison with oral iron sulphate in patients with non-myeloid malignancies associated with chemotherapy-induced anaemia  - G. Birgegard
  • Biosimilar filgrastim and chemotherapy-induced neutropenia: Overall results of the next study  - D. Kamioner

Best Supportive Care in Patients with Haematological Malignancies

  • Supportive care in haematology  - L. Jeldsen
  • General management of neutropenic patients  - P. Combrez
  • Nursing evidence and controversies in infection prevention  - A. Mank
  • Outpatient bone marrow transplantation - W. Hogan
  • Risk of hyponatremia in cancer patients treated with targeted therapies: A meta-analysis of clinical trials  - R. Berardi

Bone Health

  • Prevention of osteoporosis in cancer patients  - J. Body
  • Bone metastases: What is new what is targeted?  - M.Aapro
  • Treatment and prevention of osteonecrosis of the jaw associated with medication  - E. Papadopoulou
  • Palliative surgical intent in the treatment of bone sarcomas: A midterm review from a resource-challenged environment  - S. Khan
  • Risk of osteoporosis subsequent to chemotherapy in early-stage breast cancer  - C. Christensen

Pediatrics and Patient Care

  • Development of clinical practice guidelines for supportive care in childhood cancer in the Netherlands: Current variations in supportive care practice  - E.A.H. Loeffen
  • Toxicity is associated with age and body mass index in NOPHO-AML 2004  - D.Lohmann
  • Care coordination experience of patients with colorectal cancer: A population-based study  - I. Durcinoska
  • Patient satisfaction with cancer-related care: Language-based differential item functioning  - P .Jean-Pierre

Novel Therapies and Best Supportive Care in Cutaneous Malignancies

  • Efficacy of agents targeting the BRAF-MEK pathway  - P. Gerber
  • Efficacy of immune checkpoint inhibitors  - I.M. Svane
  • Systemic toxicities from BRAF-MEK pathway and immune checkpoint inhibitors  - V. Sibaud
  • Dermatologic toxicities from BRAF-MEK pathway and immune checkpoint inhibitors  - M. Lacouture

Saturday, June 27th

Management of Patients with Delirium

  • State-of-the-art lecture - E. Bruera

The Oncologic Tsunami

  • Older cancer patients survive - Are we prepared?  - M.A. Gosney
  • Reality of supportive care in the developing world - I. Olver

Supportive Care in Lung Cancer

  • Management of NSCLC: State of the art  - W.E. Eberhardt
  • Dyspnea: Magnitude of the problem and management - S. Ahmedzai
  • New options in the management of hyponatremia - M. Davis
  • Quality of life in lung cancer  - R. Gralla
  • Overall Survival after palliative thoracic radiotherapy for locally advanced non-small-cell lung cancer not suitable for curative-intended treatment  - H. Hansen

Nutrition and Cancer Cachexia

  • State-of-the-art lecture  - F. Strasser

Fatigue

  • How do we define fatigue and what is new? - K. Olson
  • Compassion fatigue: How to deal with it  - E. Van Muilekom
  • Fatigue in advanced cancer  - A. Charalambous
  • Randomized trial of yoga versus strengthening exercises in breast cancer survivors with persistent fatigue  - D. Stan

Cancer Pain: Opioids and Beyond

  • Neuronal mechanisms and targeted therapy of bone cancer pain  - S.Ahmedzai
  • Understanding visceral pain: Origins and treatments  - S. Mercadante
  • Cancer pain at the end of life: Rational and realistic management choices  - E. Bruera
  • Efficacy, safety and tolerability of fulranumab as adjunctive therapy for cancer related pain: A reandomized, double-blind, placebo-controlled, multicenter study  - N. Slatkin
  • Comparison of upper and lower extremity characterization of chemotherapy-induced neuropathy using patient-reported outcome measures  - C. Miaskowski

Chemotherapy-Induced Nausea and Vomiting

  • Emetic risk classification of antineoplastic agents  - P. Hesketh
  • Use of antiemetics targeting a single receptor  - K. Jordan
  • Use of antiemetics targeting multiple receptors  - D. Warr
  • Use of antiemetics in chemoradiation  - C. Ruhlmann
  • Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: A cross-sectional multinational survey  - C. Vidall

Closing ceremony

  • D. Warr, J. Herrstedt, O. Nicolatou-Galitis, D. Keefe

Fever of Unknown Origin

  • State-of-the-art lecture - J. Klastersky

How to Write a Manuscript for Supportive Care in Cancer

  • The editors’ view  - F. Ashbury
  • The authors’ view  - P. Hesketh
  • The reviewers’ view  - I. Olver

Nutrition and Cancer Cachexia

  • Swallow assessment in head and neck cancer patients treated with multi-modality therapy: Comparison over time of self report, physical exam findings and objective measures  - M. Maddalo
  • Dietary and exercise interventions to improve quality of life, metabolic risk factors and androgen deficiency symptoms in men with prostate cancer undergoing androgen deprivation therapy  - L Teleni
  • Cancer malnutrition and clinical outcomes: Results from two point prevalence studies in Australia  - K. Marshall
  • Exploring potential benefit of earlier nutritional interventions in adults with upper gastrointestinal cancer: A randomised trial  - M. Silvers
  • Results from Romana 1 and 2: Two phase-3 trials of anamorelin in advanced non-small-cell long cancer patients with cachexia  - D. Currow
  • Results from Romana 3: A safety extension study of anamorelin in advanced non-small-cell lung cancer patients with cachexia  - D. Currow
  • Validating assessment of skeletal muscle mass at L1 on chest CT scan in evaluating cancer cachExia and sarcopenia in patients with lung cancer  - A. Recio-Boiles

Oral infection in the Cancer Patient

  • Changes in the oral microbiome related to cancer and cancer therapy  - A. Stringer
  • Bacteremia associated with periodontal and dental infections  - J. Raber-Durlacher
  • Oral fungal infections  - R. Lalla
  • Antimicrobial resistance  - Y. Soga

Potentially Malignant Oral Lesions

  • Differential diagnosis of oral leukoplakia and leukoplakic lesions - I. van der Waal
  • Clinical adjunctive procedures to diagnose PML - J. Epstein
  • Biological adjunctive procedures to diagnose PML  - R. Logan

Mucositis

  • Updates on clinical studies of palifermin for oral and gastrointestinal mucositis  - N.M.A Blijlevens 
  • Clonidine mucoadhesive buccal tablet prevents severe radiomucositis in head and neck cancer patients: A phase 2 randomized trial  - R .Bensadoun
  • Effectiveness of low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in children  - A. Majorana

Chemotherapy-Induced Neurological Complications

  • Genomic risks for developing CIPN  - L. Echhoff
  • Treatment of CIPN  - C. Loprinzi
  • Evidence-based caring for patients with CIPN  - A. Margulies
  • Chemotherapy-induced peripheral neuropathy in multiple myeloma patients: Influence on quality of life and validation of a questionnaire for daily clinical practice  - A. Beijers
  • Can pregabalin prevent paclitaxel-associated neuropathy: A pilot trial  - S. Shinde

Supportive Care in Breast Cancer: The Significance of Lifestyle

  • Healthy diet and lifestyle for breast cancer patients  - C. Lacerda
  • Smoking as an independent risk factor for radiotherapy-induced skin reactions in breast cancer  - L. Sharp
  • Racial differences in early symptom management, hospice use, and intensity of end-of-life care among elderly women with breast cancer  - C. Samuel
  • Standardizing lymphedema assessment practices: A quality improvement initiative in Alberta, Canada  - M. McNeely

Rehabilitation

  • Rehabilitation of older adults with cancer  - C. Steer
  • Lessons to be learned from rehabilitation of non-cancer patients  - A.D. Olsen Zwisler
  • Optimization of cancer rehabilitation  - A. Cheville
  • Patient activation through counseling and exercise: Acute leukemia trial — A randomized controlled trial  - M.Jarden
  • The mediating role of perceived disability in the long-term impact of arm morbidity on breast cancer survivors’ emotional well-being  - T.Hack

MASCC AFSOS Symposium

  • Back home: Evidence for supportive network — How, when and for whom?  - M. Lemonde
  • Mucositis guidelines: An update  - R.J. Bensadoun
  • Breathlessness at the palliative time: From guidelines to practice  - C .Mazzocato
  • European supportive care associations in MASCC: from AFSOS to NICSO  - I. Krakowski

Skin Toxicity

  • Assessment of skin toxicity  - C.Boers-Doets
  • Case 1. Chemotherapy  - M. Lacouture
  • State of the art: Chemotherapy-induced skin toxicity  - M. Lacouture
  • Case 2. Targeted Therapy  - J. Choi
  • State of the art: Targeted therapy-induced skin toxicity  - J. Choi